ArticleFish physiology and biochemistry2026
Protective effects of Quercus brantii fruit extract against oxytetracycline-induced intestinal injury in zebrafish larvae.
Article in Fish physiology and biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Zebrafish (Danio rerio) is widely used as a vertebrate model to study intestinal inflammation due to structural and functional similarities of its gastrointestinal tract to mammals. Oxytetracycline (OTC), a commonly used antibiotic in aquaculture, can accumulate in aquatic organisms and disrupt gut homeostasis, inducing oxidative stress and inflammatory responses. This study evaluated the protective effects of hydroalcoholic Quercus brantii fruit extract against OTC-induced intestinal injury in zebrafish larvae. A total of 144 three-day-old larvae were randomly assigned to four experimental groups (n = 36 per group, three replicates of 12 larvae): control (untreated), OTC (10 mg/L for five days), OTC + Quercus brantii fruit extract 10 g/kg diet, and OTC + Quercus brantii fruit extract 20 g/kg diet. Histopathological analysis revealed that OTC exposure caused partial epithelial disruption, reduced mucosal fold height, decreased goblet cell density, and increased infiltration of inflammatory cells. Cotreatment with 10 g/kg Quercus brantii fruit extract partially ameliorated these changes, whereas 20 g/kg significantly preserved epithelial integrity, increased mucosal fold height, and reduced inflammatory cell infiltration. Gene expression analysis showed that OTC significantly upregulated NF-κB, TNF-α, and IL-6 levels. Administration of 10 g/kg Quercus brantii fruit extract reduced NF-κB and TNF-α expression but did not significantly affect IL-6, while 20 g/kg extract significantly decreased all three cytokines. These results indicate that hydroalcoholic Quercus brantii fruit extract exerts protective effects against OTC-induced intestinal injury, likely mediated through NF-κB inhibition.
Indexed as
Identifiers
42684509What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.